| Control subjects | GDM | p-value |
---|---|---|---|
Fasting glucose (mmol/l) | 5.03 ± 0.46 | 5.42 ± 1.64* | 0.01 |
Fasting insulinemia (μUI/ml) | 10.59 ± 11.1 | 13.19 ± 10.05 | 0.67 |
Triglyceride (mmol/l) | 1.99 ± 0.23 | 2.4 ± 0.93 | 0.38 |
Total cholesterol (mmol/l) | 5.12 ± 1.26 | 5.43 ± 1.54** | <0.0001 |
HDL cholesterol (mmol/l) | 1.47 ± 0.55 | 1.31 ± 0.3* | 0.018 |
LDL cholesterol (mmol/l) | 2.59 ± 1.39 | 2.94 ± 1.27 | 0.47 |
Apo A1 (g/l) | 1.90 ± 0.7 | 1.50 ± 0.34** | 0.001 |
Apo B (g/l) | 1.36 ± 0.5 | 1.22 ± 0.43 | 0.64 |
Urea (mmol/l) | 3.83 ± 1.16 | 2.44 ± 0.89* | 0.050 |
Creatinine (μmol/l) | 49.99 ± 0.15 | 50.74 ± 8.76 | 0.6 |
HbAc (%) | 5.27 ± 0.5 | 6.7 ± 1.21* | 0.002 |
HOMA-IR | 1.53 ± 0.51 | 2.38 ± 1.39* | 0.02 |
Adiponectin (μg/ml) | 10.02 ± 1.1 | 8.58 ± 1.7* | 0.01 |
IL-6 (pg/ml) | 53.17 ± 1.45 | 77.84 ± 10.98* | 0.002 |
TNF-α (pg/ml) | 61.75 ± 6.5 | 71.63 ± 12.33 | 0.091 |
C-reactive protein (mg/dl) | 0.86 ± 1.1 | 0.80 ± 1.4 | 0.716 |
FSBF endothelium-dependent (%) | 1176.38 ± 531.67 | 344.59 ± 305.81* | 0.037 |